|
| Gender (%) | Male 38 (84%)
Female 7 (16%) |
|
| Cause of Liver Disease | |
| HBV | 18 |
| HCV | 19 |
| ETOH | 5 |
| Hemochrmatosis | 1 |
|
| Age at Diagnosis | 62.8 years |
|
| Average Survival after HCC Diagnosis | 28 months |
|
| Average Survival after PVT Diagnosis | 15 months |
|
Total Patient
45
Anticoagulation
No
Yes
Initial PVT Involvement
Right PVT 18 (40%)
Left PVT 13 (28%)
Main PVT 6 (13%)
Multi Involvement 8 (17%) | PVT Progression
23
19 (49%)
4 (67%)
12 (67%)
7 (54%)
4 (67%) |
|
| HCC type | |
| Single Lesion | 30 (67%) |
| Multifocal | 15 (33%) |
|
| HCC Treatment Modality | |
| TACE | 19 (42%) |
| RFA | 3 (7%) |
| TACE + RFA | 8 (18%) |
| Systemic Treatment | 35 (78%) |
|
| MELD Score (average) | 8.25 |
|
| Child | A (71%), B (29%) |
|
